Veracyte: UBS maintains Buy, raises PT to $48 from $42.

Wednesday, Nov 5, 2025 6:16 pm ET1min read
VCYT--

Veracyte: UBS maintains Buy, raises PT to $48 from $42.

Veracyte: UBS maintains Buy, raises PT to $48 from $42.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet